5-Hydroxyindoleacetic acid (5HIAA) and homovanillic acid (HVA) following probenecid in acute psychotic patients treated with phenothiazines.
D002986:Clinical Trials as Topic; D003863:Depression / Q000134:cerebrospinal fluid / Q000188:drug therapy; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D010640:Phenothiazines / Q000627:therapeutic use*; D010648:Phenylacetates / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D011339:Probenecid / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy
D010640:Phenothiazines; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid